These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 34004222)

  • 1. The impact of primary care supported shielding on the risk of mortality in people vulnerable to COVID-19: English sentinel network matched cohort study.
    Zarif A; Joy M; Sherlock J; Sheppard JP; Byford R; Akinyemi O; Bankhead CR; Deeks A; Ferreira F; Jones N; Liyanage H; McGagh D; Nicholson B; Oke J; Okusi C; Tripathy M; Williams J; Hobbs R; de Lusignan S
    J Infect; 2021 Aug; 83(2):228-236. PubMed ID: 34004222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of Shielding Behavior During the COVID-19 Pandemic and Associations With Well-being Among National Health Service Patients: Longitudinal Observational Study.
    Bachtiger P; Adamson A; Maclean WA; Kelshiker MA; Quint JK; Peters NS
    JMIR Public Health Surveill; 2021 Sep; 7(9):e30460. PubMed ID: 34298499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shielding reduced incidence of COVID-19 in patients with inflammatory arthritis but vulnerability is associated with increased mortality.
    Cooksey R; Underwood J; Brophy S; Atkinson M; Kennedy J; Choy E
    Rheumatology (Oxford); 2022 Jun; 61(SI2):SI120-SI128. PubMed ID: 35567479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability and feasibility of strategies to shield the vulnerable during the COVID-19 outbreak: a qualitative study in six Sudanese communities.
    Abdelmagid N; Ahmed SAE; Nurelhuda N; Zainalabdeen I; Ahmed A; Fadlallah MA; Dahab M
    BMC Public Health; 2021 Jun; 21(1):1153. PubMed ID: 34134680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of shielding during the COVID-19 pandemic on mental health: evidence from the English Longitudinal Study of Ageing.
    Di Gessa G; Price D
    Br J Psychiatry; 2022 Oct; 221(4):637-643. PubMed ID: 35369895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects on mortality of shielding clinically extremely vulnerable patients in Liverpool, UK, during the COVID-19 pandemic.
    Filipe L; Barnett LA; Piroddi R; Buchan I; Duckworth H; Barr B
    Public Health; 2023 Sep; 222():54-59. PubMed ID: 37523949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of the burden of shielding among a cross-section of patients attending rheumatology clinics with SLE-data from the BSR audit of systemic lupus erythematosus.
    Rutter M; Lanyon PC; Sandhu R; Batten RL; Garner R; Little J; Narayan N; Sharp CA; Bruce IN; Erb N; Griffiths B; Guest H; Macphie E; Packham J; Hiley C; Obrenovic K; Rivett A; Gordon C; Pearce FA
    Rheumatology (Oxford); 2021 Mar; 60(3):1474-1479. PubMed ID: 33677595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Did the UK's public health shielding policy protect the clinically extremely vulnerable during the COVID-19 pandemic in Wales? Results of EVITE Immunity, a linked data retrospective study.
    Snooks H; Watkins A; Lyons J; Akbari A; Bailey R; Bethell L; Carson-Stevens A; Edwards A; Emery H; Evans BA; Jolles S; John A; Kingston M; Porter A; Sewell B; Williams V; Lyons RA
    Public Health; 2023 May; 218():12-20. PubMed ID: 36933354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of COVID-19 in patients with rheumatic disease: is prior health education more important than shielding advice during the pandemic?
    Kipps S; Paul A; Vasireddy S
    Clin Rheumatol; 2021 Apr; 40(4):1575-1579. PubMed ID: 33174109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excess mortality in the first COVID pandemic peak: cross-sectional analyses of the impact of age, sex, ethnicity, household size, and long-term conditions in people of known SARS-CoV-2 status in England.
    Joy M; Hobbs FR; Bernal JL; Sherlock J; Amirthalingam G; McGagh D; Akinyemi O; Byford R; Dabrera G; Dorward J; Ellis J; Ferreira F; Jones N; Oke J; Okusi C; Nicholson BD; Ramsay M; Sheppard JP; Sinnathamby M; Zambon M; Howsam G; Williams J; de Lusignan S
    Br J Gen Pract; 2020 Dec; 70(701):e890-e898. PubMed ID: 33077508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of severe COVID-19 in Scotland to transmission-related factors and risk conditions eligible for shielding support: REACT-SCOT case-control study.
    McKeigue PM; McAllister DA; Caldwell D; Gribben C; Bishop J; McGurnaghan S; Armstrong M; Delvaux J; Colville S; Hutchinson S; Robertson C; Lone N; McMenamin J; Goldberg D; Colhoun HM
    BMC Med; 2021 Jun; 19(1):149. PubMed ID: 34158021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in health and social well-being in the COVID-19 clinically vulnerable older English population during the pandemic.
    Di Gessa G; Price D
    J Epidemiol Community Health; 2021 Nov; 75(11):1070-1077. PubMed ID: 33947747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of hospitalized patients with COVID-19 who did and did not live in residential care facilities in Montréal: a retrospective case series.
    Mah J; Lieu A; Palayew M; Alipour P; Kong LY; Song S; Palayew A; Tutt-Guérette MA; Yang SS; Wilchesky M; Lipes J; Azoulay L; Greenaway C
    CMAJ Open; 2021; 9(3):E718-E727. PubMed ID: 34257090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of COVID-19 in shielded and nursing care home patients: a cohort study in general practice.
    Wingfield D; Taghavi Azar Sharabiani M; Majeed A; Molokhia M
    BJGP Open; 2021; 5(6):. PubMed ID: 34446435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records.
    Taquet M; Geddes JR; Husain M; Luciano S; Harrison PJ
    Lancet Psychiatry; 2021 May; 8(5):416-427. PubMed ID: 33836148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IMPACT-Restart: the influence of COVID-19 on postoperative mortality and risk factors associated with SARS-CoV-2 infection after orthopaedic and trauma surgery.
    Clement ND; Hall AJ; Makaram NS; Robinson PG; Patton RFL; Moran M; Macpherson GJ; Duckworth AD; Jenkins PJ
    Bone Joint J; 2020 Dec; 102-B(12):1774-1781. PubMed ID: 33249904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of COVID-19 outcomes among shielded and non-shielded populations.
    Jani BD; Ho FK; Lowe DJ; Traynor JP; MacBride-Stewart SP; Mark PB; Mair FS; Pell JP
    Sci Rep; 2021 Jul; 11(1):15278. PubMed ID: 34315958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of the COVID-19 epidemic in Friuli Venezia Giulia Region (Northern Italy): assessment of factors associated with the risk of death by competing risks analysis].
    Castriotta L; Rosolen V; Barbiero F; Tomietto M; de Dottori M; Barbone F; Zamaro G
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):128-135. PubMed ID: 33412803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics and Outcomes of COVID-19 Cohort Patients in Daegu Metropolitan City Outbreak in 2020.
    Kim SW; Kim SM; Kim YK; Kim JY; Lee YM; Kim BO; Hwangbo S; Park T
    J Korean Med Sci; 2021 Jan; 36(1):e12. PubMed ID: 33398946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost of implementing the COVID-19 shielding policy in Wales.
    Sewell B; Farr A; Akbari A; Carson-Stevens A; Dale J; Edwards A; Evans BA; John A; Torabi F; Jolles S; Kingston M; Lyons J; Lyons RA; Porter A; Watkins A; Williams V; Snooks H
    BMC Public Health; 2023 Nov; 23(1):2342. PubMed ID: 38008730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.